AstraZeneca AG

Pharmaceutical Industry in Sweden - Includes Data on Market Size and Segmentation, Key Trends and Competitive Landscape, Leading Companies & Much More.
M2 Presswire; 11/5/2009; 854 words; ...Industry F. Leading Players in the Market F.1 AstraZeneca Plc F.2 Pfizer Inc F.3 Novartis AG G. Appendix G.1 Offshoring in the Pharmaceutical...Companies Mentioned: - Pfizer Inc - Novartis AG - AstraZeneca Plc For more information visit http://www...

Research and Markets: Pharmaceutical Industry in Sweden - Includes Data on Market Size and Segmentation, Key Trends and Competitive Landscape, Leading Companies & Much More.
Business Wire; 11/5/2009; 992 words; ...Industry F. Leading Players in the Market F.1 AstraZeneca Plc F.2 Pfizer Inc F.3 Novartis AG G. Appendix G.1 Offshoring in the Pharmaceutical...Companies Mentioned: * Pfizer Inc * Novartis AG * AstraZeneca Plc For more information visit http://www...

Seattle Genetics Highlights Pipeline Progress and Reports Third Quarter 2009 Financial Results.(Financial report)
Blood Weekly; 11/5/2009; 2227 words; ...agreement with MedImmune, LLC, a wholly owned subsidiary of AstraZeneca, triggered by its initiation of a phase I clinical trial of...milestone payment under collaboration with Bayer Schering Pharma AG, Germany, triggered by Bayer's submission of an IND application...

Genentech's Avastin Phase III Misses Breast Cancer Endpoint.
BIOWORLD Today; 11/4/2009; 1304 words; ...suffered fallout from the failure of Iressa, London-based AstraZeneca plc's EGFR inhibitor for cancer. (See BioWorld Today...partnered with Basel, Switzerland-based Novartis Pharma AG, by the end of the year. Lowering Genentech's rating from...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2158 words; ...collaboration between the Institute of Cancer Research in Sutton, UK; AstraZeneca plc, of London; and BTG. o Endo Pharmaceuticals Holdings...for later this year. The product is partnered with Schering AG, of Berlin. EPIX's shares (NASDAQ:EPIX) gained $4...